YUMANITY THERAPEUTICS INC's ticker is YMTX and the CUSIP is 98872L102. A total of 31 filers reported holding YUMANITY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,557,000 | -13.6% | 1,628,470 | +0.1% | 0.00% | – |
| Q2 2022 | $2,961,000 | +21.5% | 1,627,011 | +0.2% | 0.00% | – |
| Q1 2022 | $2,437,000 | -46.8% | 1,624,462 | +5.1% | 0.00% | – |
| Q4 2021 | $4,577,000 | -39.9% | 1,546,252 | +109.7% | 0.00% | -100.0% |
| Q3 2021 | $7,610,000 | -44.9% | 737,447 | -37.8% | 0.00% | 0.0% |
| Q2 2021 | $13,818,000 | -33.5% | 1,186,089 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $20,788,000 | +14.6% | 1,186,089 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $18,147,000 | – | 1,186,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 108,847 | $1,850,000 | 1.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,434 | $2,217,000 | 0.20% |
| HARBOURVEST PARTNERS LLC | 22,030 | $375,000 | 0.15% |
| Redmile Group, LLC | 611,003 | $10,387,000 | 0.13% |
| Ikarian Capital, LLC | 132,514 | $2,253,000 | 0.10% |
| Artal Group S.A. | 217,391 | $3,696,000 | 0.08% |
| Maven Securities LTD | 43,478 | $739,000 | 0.07% |
| Bain Capital Public Equity Management II, LLC | 31,331 | $533,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 14,498 | $246,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11,000 | $187,000 | 0.00% |